AVO's U.K. momentum fuels its Europe push, with rising demand and stronger retailer ties pointing to the company's next major growth frontier.

U.S. airlines will see an impact of those slower bookings in their fourth quarter, which usually ties with second quarter and the start of the summer as their strongest for sales.

PHILADELPHIA , Nov. 18, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against James Hardie Industries plc (NYSE: JHX) ("James Hardie" or the "Company") on behalf of investors who purchased James Hardie common stock or American Depositary Shares during the period of May 20, 2025 through August 18, 2025 (the "Class Period"). Investor Deadline: Investors who purchased James Hardie securities during the Class Period may, no later than December 23, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Singapore, Singapore--(Newsfile Corp. - November 18, 2025) - FingerMotion, Inc. (NASDAQ: FNGR) ("FingerMotion" or the "Company"), a mobile services, data, and technology company, today announces the next phase of its strategic roadmap, which focuses on expanding its technology platforms and monetizing the core competencies developed in China for broader regional markets. Over the past years, FingerMotion has built a strong foundation through its mobile recharge and top-up platform, data-driven analytics, and technology collaborations across multiple sectors.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”). Skye is a clinical stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Alleg.

WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.

TQQQ is the cleanest, most liquid 3x Nasdaq-100 ETF, with tight spreads and a reasonable 0.82% yearly fee. TQQQ has outperformed QQQ and peers over the past 15 years, driven by a secular tech bull market and recently AI. This made me rethink my approach to leveraged investing. For short-term AI rebound trades, I still favor SOXL over TQQQ; semiconductors capture the most upside if an AI hype cycle is to reignite. Long term, I am considering TQQQ.

CLS' new SD6300 storage system targets soaring AI data needs with an ultra-dense design aimed at boosting performance and cost efficiency.

Does TIM S.A. Sponsored ADR (TIMB) have what it takes to be a top stock pick for momentum investors?

Oric Pharmaceuticals (ORIC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TriMas (TRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

First Bank (FRBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ADC Therapeutics (ADCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Ares Commercial Real Estate (ACRE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Jade Biosciences, Inc. (JBIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Virgin Galactic (SPCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PLBY Group (PLBY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

WALLDORF, Germany , Nov. 18, 2025 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced a new collaboration with France's AI sector, which includes new and expanded partnerships with Bleu, Capgemini, and Mistral AI. The collaboration will combine SAP enterprise application expertise with France's vibrant AI ecosystem to create secure, scalable, AI-driven sovereign cloud solutions that protect data and intellectual property while advancing Europe's digital transformation.

During 2025, PG&E customers have lost nearly $300,000 to scammers OAKLAND, Calif. , Nov. 18, 2025 /PRNewswire/ -- As the holiday season gets underway, Pacific Gas and Electric Company (PG&E) is joining Utilities United Against Scams to help customers recognize potential scams and to "slow down, verify and stop the scam" as part of Utility Scam Awareness Day on November 19.